Drug safety watch: tracking arthritis medication in real patients
NCT ID NCT04876781
Summary
This study is monitoring the safety and effectiveness of the arthritis medication Xeljanz XR in routine medical practice in Korea. It will follow at least 200 adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who are already prescribed this medication. The main goal is to track any side effects that occur during the first 6 months of treatment while also checking if the drug helps control their arthritis symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE MODERATE TO SEVERE RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.